Wells Fargo’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
1,043,655
+1,039,031
| +22,470% | +$18M | ﹤0.01% | 1352 |
|
|
2025
Q1 | $101K | Sell |
4,624
-992
| -18% | -$21.7K | ﹤0.01% | 4653 |
|
|
2024
Q4 | $179K | Sell |
5,616
-133,752
| -96% | -$4.27M | ﹤0.01% | 4378 |
|
|
2024
Q3 | $4.02M | Sell |
139,368
-20,860
| -13% | -$602K | ﹤0.01% | 2277 |
|
|
2024
Q2 | $6.15M | Buy |
160,228
+15,193
| +10% | +$583K | ﹤0.01% | 1930 |
|
|
2024
Q1 | $8.53M | Buy |
145,035
+12,468
| +9% | +$733K | ﹤0.01% | 1695 |
|
|
2023
Q4 | $7.94M | Sell |
132,567
-23,140
| -15% | -$1.39M | ﹤0.01% | 1695 |
|
|
2023
Q3 | $5.92M | Buy |
155,707
+63,512
| +69% | +$2.42M | ﹤0.01% | 1855 |
|
|
2023
Q2 | $8.4M | Sell |
92,195
-13,423
| -13% | -$1.22M | ﹤0.01% | 1652 |
|
|
2023
Q1 | $6.97M | Buy |
105,618
+88,673
| +523% | +$5.85M | ﹤0.01% | 1755 |
|
|
2022
Q4 | $876K | Sell |
16,945
-2,653
| -14% | -$137K | ﹤0.01% | 3129 |
|
|
2022
Q3 | $1.34M | Buy |
19,598
+3,796
| +24% | +$259K | ﹤0.01% | 2859 |
|
|
2022
Q2 | $714K | Sell |
15,802
-25,617
| -62% | -$1.16M | ﹤0.01% | 3316 |
|
|
2022
Q1 | $2.11M | Sell |
41,419
-22,506
| -35% | -$1.14M | ﹤0.01% | 3059 |
|
|
2021
Q4 | $3.02M | Buy |
63,925
+13,336
| +26% | +$630K | ﹤0.01% | 2906 |
|
|
2021
Q3 | $1.67M | Buy |
50,589
+14,390
| +40% | +$474K | ﹤0.01% | 3628 |
|
|
2021
Q2 | $2.29M | Buy |
36,199
+26,162
| +261% | +$1.65M | ﹤0.01% | 3399 |
|
|
2021
Q1 | $430K | Sell |
10,037
-38,386
| -79% | -$1.64M | ﹤0.01% | 4467 |
|
|
2020
Q4 | $2.77M | Buy |
48,423
+21,959
| +83% | +$1.26M | ﹤0.01% | 3224 |
|
|
2020
Q3 | $799K | Sell |
26,464
-14,136
| -35% | -$427K | ﹤0.01% | 3931 |
|
|
2020
Q2 | $1.33M | Buy |
40,600
+9,828
| +32% | +$321K | ﹤0.01% | 3519 |
|
|
2020
Q1 | $825K | Sell |
30,772
-27,773
| -47% | -$745K | ﹤0.01% | 3570 |
|
|
2019
Q4 | $1.79M | Buy |
58,545
+13,067
| +29% | +$400K | ﹤0.01% | 3393 |
|
|
2019
Q3 | $1.1M | Buy |
45,478
+1,480
| +3% | +$35.6K | ﹤0.01% | 3715 |
|
|
2019
Q2 | $1.12M | Buy |
43,998
+20,272
| +85% | +$514K | ﹤0.01% | 3737 |
|
|
2019
Q1 | $463K | Sell |
23,726
-1,802
| -7% | -$35.2K | ﹤0.01% | 4329 |
|
|
2018
Q4 | $337K | Buy |
25,528
+7,617
| +43% | +$101K | ﹤0.01% | 4445 |
|
|
2018
Q3 | $318K | Buy |
17,911
+1,088
| +6% | +$19.3K | ﹤0.01% | 4599 |
|
|
2018
Q2 | $370K | Buy |
16,823
+10,674
| +174% | +$235K | ﹤0.01% | 4546 |
|
|
2018
Q1 | $136K | Buy |
6,149
+4,553
| +285% | +$101K | ﹤0.01% | 4954 |
|
|
2017
Q4 | $35K | Buy |
+1,596
| New | +$35K | ﹤0.01% | 5330 |
|